Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion

Sareen, D; O'Rourke, JG; Meera, P; Muhammad, AK; Grant, S; Simpkinson, M; Bell, S; Carmona, S; Ornelas, L; Sahabian, A; Gendron, T; Petrucelli, L; Baughn, M; Ravits, J; Harms, MB; Rigo, F; Bennett, CF; Otis, TS; Svendsen, CN; Baloh, RH

HERO ID

2900156

Reference Type

Journal Article

Year

2013

Language

English

PMID

24154603

HERO ID 2900156
In Press No
Year 2013
Title Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion
Authors Sareen, D; O'Rourke, JG; Meera, P; Muhammad, AK; Grant, S; Simpkinson, M; Bell, S; Carmona, S; Ornelas, L; Sahabian, A; Gendron, T; Petrucelli, L; Baughn, M; Ravits, J; Harms, MB; Rigo, F; Bennett, CF; Otis, TS; Svendsen, CN; Baloh, RH
Journal Science Translational Medicine
Volume 5
Issue 208
Page Numbers 208ra149
Abstract Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative condition characterized by loss of motor neurons in the brain and spinal cord. Expansions of a hexanucleotide repeat (GGGGCC) in the noncoding region of the C9ORF72 gene are the most common cause of the familial form of ALS (C9-ALS), as well as frontotemporal lobar degeneration and other neurological diseases. How the repeat expansion causes disease remains unclear, with both loss of function (haploinsufficiency) and gain of function (either toxic RNA or protein products) proposed. We report a cellular model of C9-ALS with motor neurons differentiated from induced pluripotent stem cells (iPSCs) derived from ALS patients carrying the C9ORF72 repeat expansion. No significant loss of C9ORF72 expression was observed, and knockdown of the transcript was not toxic to cultured human motor neurons. Transcription of the repeat was increased, leading to accumulation of GGGGCC repeat-containing RNA foci selectively in C9-ALS iPSC-derived motor neurons. Repeat-containing RNA foci colocalized with hnRNPA1 and Pur-α, suggesting that they may be able to alter RNA metabolism. C9-ALS motor neurons showed altered expression of genes involved in membrane excitability including DPP6, and demonstrated a diminished capacity to fire continuous spikes upon depolarization compared to control motor neurons. Antisense oligonucleotides targeting the C9ORF72 transcript suppressed RNA foci formation and reversed gene expression alterations in C9-ALS motor neurons. These data show that patient-derived motor neurons can be used to delineate pathogenic events in ALS.
Doi 10.1126/scitranslmed.3007529
Pmid 24154603
Is Certified Translation No
Dupe Override No
Is Public Yes
Language Text English